Related Experiment Videos
What is your diagnosis? Blood from a 4-year-old Basset hound
Joanne B. Messick1, Barbara Biller, Barbara E. Kitchell
1Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Veterinary Clinical Pathology
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009-2018).
Veterinary and comparative oncology·2020
Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
Journal of the American Animal Hospital Association·2019
Metronomic chemotherapy in veterinary patients with cancer: rethinking the targets and strategies of chemotherapy.
The Veterinary clinics of North America. Small animal practice·2014
Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease.
The Canadian veterinary journal = La revue veterinaire canadienne·2003
Eosinophilic Cerebrospinal Fluid Pleocytosis in A Dog With Hypertrophic Pachymeningitis and Generalized Eosinophilic Disease.
Veterinary clinical pathology·2026
Two Cases of Feline Hepatosplenic Cytotoxic T-Cell Lymphoma With Hemophagocytosis.
Veterinary clinical pathology·2026
Preliminary Reference Interval Estimation for Hemolymph Analysis in Free-Ranging Mangrove Horseshoe Crab (Carcinoscorpius rotundicauda).
Veterinary clinical pathology·2026
Evaluation of a Commercially Available Canine C-Reactive Protein Assay Across Institutions and After 2 Years of Frozen Storage.
Veterinary clinical pathology·2026
Acute Myeloid Leukemia With Suspected Basophilic Differentiation in a Cat Negative for Feline Leukemia Virus.
Veterinary clinical pathology·2026
Association of Time of Day With Functional Outcome in Intracerebral Hemorrhage.
European journal of neurology·2026
Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
A new player in hemolytic uremic syndrome: the plasma kallikrein-kinin system, a target of heme.
Kidney international·2026